Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial details
- Registry ID
- NCT06619990
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisNCT06619990 | XNCR | Phase 1, Phase 2 | Recruiting | 2027-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |